Dividend-News

'Safer' Dividend Healthcare Gainers Glaxo, Pfizer & Medical Facilities Are Tagged Tops By Broker Targets For December

Published Fri, 29 Dec 2017 12:21:56 -0500 on Seeking Alpha

Actionable Conclusions (1-10): Brokers Calculated Top Ten Healthcare "Safer" Dividend Stocks to Net 0.56% to 23.2% Gains To December, 2018 Nine of ten top 'safer' dividend Healthcare dogs by yield (shaded in the chart above) were verified as being among the top ten gainers for the coming year. Thus, based on analyst 1 year target prices, the dog strategy for this Health group graded out as 90% accurate for December.
Ten probable profit generating trades were illustrated by YCharts analytics for 2018:
GlaxoSmithKline (GSK) netted $231.83 based on estimates from six analysts, plus dividends less broker fees. The Beta number showed this estimate subject to volatility 2% less than the market as a whole.
Pfizer (PFE) netted $68.91 based on dividends plus median target price estimate from twenty-five analysts less broker fees. The Beta number showed this estimate subject to volatility 2% over the market as a whole.
Medical Facilities (OTCPK: MFCSF) netted $58.68 based on no target price estimate from analysts, just projected annual dividend less broker fees. The Beta number showed this estimate subject to volatility 45% less than the market as a whole.
HealthSouth (HLS) netted $46.24 based on a median target from thirteen analysts, plus dividends, less broker fees. The Beta number showed this estimate subject to volatility 44% less than the market as a whole.
Johnson & Johnson (JNJ) netted $39.69 based on estimates from twenty-five analysts,... Read more